KalVista Pharmaceuticals, Inc. (KALV) Stock Analysis
DELISTED 2026
What happened to KalVista Pharmaceuticals, Inc. (KALV) stock?
KalVista Pharmaceuticals, Inc. (KALV) no longer trades on public markets. It was delisted in June 2026. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- June 2026
- Last recorded price (historical):
- $27.00 (last quote on record before the June 2026 delisting; historical, not a current quote)
Market cap $1.44B is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
KalVista Pharmaceuticals, Inc. (KALV). KalVista Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing small molecule protease inhibitors.
Last analyzed: May 10, 2026These figures come from statements filed 13 months ago — the most recent this company has published.
KalVista Pharmaceuticals, Inc. (KALV) Healthcare & Pipeline Overview
More about this archive record
Can I still buy KALV shares?
No. KALV stopped trading on public markets in June 2026, so the shares are not available through a broker. Anything you see quoted for KALV elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before KALV stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to KalVista Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.